# Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma

> **NCT06943703** · — · COMPLETED · sponsor: **National Children's Hospital, Vietnam** · enrollment: 809 (actual)

## Conditions studied

- Lymphangioma
- Lymphatic Malformations

## Interventions

- **DRUG:** Sclerotherapy with intralesional bleomycin injection

## Key facts

- **NCT ID:** NCT06943703
- **Lead sponsor:** National Children's Hospital, Vietnam
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2025-02-04
- **Target enrollment:** 809 (ACTUAL)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06943703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06943703, "Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06943703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*